...
首页> 外文期刊>Electrophoresis: The Official Journal of the International Electrophoresis Society >Two-dimensional difference fluorescence gel electrophoresis to verify the scale-up of a non-affinity-based downstream process for isolation of a therapeutic recombinant antibody.
【24h】

Two-dimensional difference fluorescence gel electrophoresis to verify the scale-up of a non-affinity-based downstream process for isolation of a therapeutic recombinant antibody.

机译:二维差异荧光凝胶电泳可验证用于分离治疗性重组抗体的基于非亲和力的下游工艺的放大规模。

获取原文
获取原文并翻译 | 示例
           

摘要

For therapeutic antibody production Protein A chromatography is often replaced by non-affinity-based purification sequences, which are considered as more economical. 2-D DIGE was applied for evaluation of scale-up of non-affinity based process of a humanized monoclonal antibody, anti-Rh(D) IgG(1), in comparison with other conventional analytical methods, like SDS-PAGE, Western blot, or SEC. Due to a high sensitivity of this technique (125 pg protein/spot) and high dynamic range of five orders of magnitude, low molecular weight impurities were detected in purified samples. Cation exchange chromatography was efficient capture step for IgG(1) purification in laboratory and pilot scale. The differences between samples after first purification step in laboratory and pilot scale were compensated with second purification step where almost the same protein pattern was observed. 2-D DIGE is a helpful tool for monitoring of purification effects and for scale-up verification of downstream processes.
机译:为了产生治疗性抗体,蛋白A色谱通常被基于非亲和力的纯化序列所取代,这被认为更经济。与其他常规分析方法(例如SDS-PAGE,蛋白质印迹)相比,将2-D DIGE用于评估基于非亲和力的人源化单克隆抗体抗Rh(D)IgG(1)的放大或SEC。由于该技术的高灵敏度(125 pg蛋白/斑点)和五个数量级的高动态范围,因此在纯化的样品中检测到了低分子量杂质。阳离子交换色谱是在实验室和中试规模纯化IgG(1)的有效捕获步骤。在实验室进行的第一个纯化步骤后和中试规模的样品之间的差异被第二个纯化步骤补偿,其中观察到几乎相同的蛋白质模式。 2-D DIGE是监测纯化效果和验证下游工艺规模的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号